Lance Boling

IRRAS Appoints Medical Technology Leader C. Lance Boling as Vice President, Product Development

11.04.17

IRRAS, a commercial-stage medical technology company developing breakthrough devices for a broad range of brain pathology therapeutic applications and procedures, today announced the appointment of C. Lance Boling as Vice President, Product Development and a member of the executive management team. Mr. Boling brings over 25 years of experience in medical device development, manufacturing, and operations to IRRAS, where he will be responsible for expanding the IRRAflow® technology portfolio in both the EU and U.S. In his role, Mr. Boling will report directly to the Chairman and CEO of IRRAS, Kleanthis G. Xanthopoulos, Ph.D., from one of the company’s U.S. sites.

Prior to joining IRRAS, Mr. Boling was Director of Nano Technology Development at Abbott Laboratories where he was responsible for leading numerous development efforts from inception through commercialization. Before Abbott, Mr. Boling held leadership positions at Nanostim, Nevro Corporation, NeuroPace, Inc., and Autonomic Technology. Mr. Boling holds a BA in Business Management from the University of Phoenix and has participated in Post Graduate studies in Manufacturing Technology at Stanford University. He holds over 40 pioneering patents – granted and pending in the medical device industry – and is a regular guest lecturer on product development at local universities and high schools.